The global Breast Cancer Treatment Devices market size is predicted to grow from US$ 36280 million in 2025 to US$ 60230 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.
Breast cancer treatment devices are medical devices used in the diagnosis, treatment, and management of breast cancer. These devices play a crucial role in detecting, staging, and treating breast cancer, as well as monitoring treatment response.
The market for breast cancer treatment devices is driven by several factors, including the increasing prevalence of breast cancer worldwide, advancements in medical technology, rise in awareness about early detection, and an aging population. Additionally, government initiatives and awareness campaigns promoting breast cancer screening have also boosted market growth.
Here are some key segments and factors driving the global breast cancer treatment devices market:
Diagnostic Devices: This segment includes mammography machines, breast ultrasound systems, breast MRI machines, and breast biopsy devices. The increasing emphasis on early detection and accurate diagnosis of breast cancer has propelled the demand for these devices.
Surgical Devices: Surgical tools and devices used in breast cancer surgeries, such as lumpectomy or mastectomy procedures, fall under this segment. The demand for precise and minimally invasive surgical techniques has driven the market for these devices.
Radiation Therapy Devices: Radiation therapy machines, including linear accelerators, targeted radiation systems, and brachytherapy devices, are used in the treatment of breast cancer. These devices deliver radiation to destroy cancer cells and reduce the risk of recurrence. The growing adoption of radiation therapy as an effective treatment option has contributed to the market growth.
Chemotherapy Devices: Devices used in the delivery of chemotherapy drugs for breast cancer treatment, such as infusion pumps and implantable ports, are part of this segment. The increasing prevalence of chemotherapy as a systemic treatment for breast cancer has driven the demand for these devices.
Other Supportive Devices: This segment includes lymphedema management devices, prosthetics, and breast reconstruction devices, which aim to improve the quality of life for breast cancer survivors. These devices help manage post-treatment side effects and provide aesthetic solutions.
Geographically, North America and Europe dominate the global breast cancer treatment devices market due to well-established healthcare infrastructure and higher awareness levels. However, emerging economies in the Asia-Pacific region and Latin America are witnessing significant growth due to improving healthcare infrastructure, rising healthcare expenditure, and growing awareness about breast cancer.
Key players in the global breast cancer treatment devices market include medical device manufacturers, imaging equipment manufacturers, and providers of surgical tools and devices. These companies focus on research and development activities to introduce innovative and technologically advanced devices to the market.
Overall, with the increasing global burden of breast cancer and advancements in medical technology, the global breast cancer treatment devices market is expected to witness substantial growth in the coming years.
The 鈥淏reast Cancer Treatment Devices Industry Forecast鈥� looks at past sales and reviews total world Breast Cancer Treatment Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Breast Cancer Treatment Devices sales for 2025 through 2031. With Breast Cancer Treatment Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Cancer Treatment Devices industry.
This Insight Report provides a comprehensive analysis of the global Breast Cancer Treatment Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Breast Cancer Treatment Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Breast Cancer Treatment Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Cancer Treatment Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Cancer Treatment Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Breast Cancer Treatment Devices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Diagnostic Imaging Devices
Surgical Procedure Devices
Directional Energy Therapy Equipment
Drug/Fluid Delivery and Infusion Therapy Devices
Others
Segmentation by Application:
Hospital
Outpatient Surgery Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Advanced Radiation Therapy
Agilent Technologies
Becton
Xcision Medical Systems, LLC
BioGenex Laboratories
Danaher Corporation
Fujifilm Holdings Corporation
GE Healthcare
General Medical Merate SpA
Hologic
iCAD Inc.
IceCure Medical Ltd
IntraOp Medical Corporation
Myriad Genetics
Parascript, LLC
Philips Healthcare
Planmed Oy
Qiagen NV
Roche Holding AG
Sanarus Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Breast Cancer Treatment Devices 麻豆原创 Size (2020-2031)
2.1.2 Breast Cancer Treatment Devices 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Breast Cancer Treatment Devices by Country/Region (2020, 2024 & 2031)
2.2 Breast Cancer Treatment Devices Segment by Type
2.2.1 Diagnostic Imaging Devices
2.2.2 Surgical Procedure Devices
2.2.3 Directional Energy Therapy Equipment
2.2.4 Drug/Fluid Delivery and Infusion Therapy Devices
2.2.5 Others
2.3 Breast Cancer Treatment Devices 麻豆原创 Size by Type
2.3.1 Breast Cancer Treatment Devices 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Breast Cancer Treatment Devices 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Breast Cancer Treatment Devices Segment by Application
2.4.1 Hospital
2.4.2 Outpatient Surgery Center
2.4.3 Other
2.5 Breast Cancer Treatment Devices 麻豆原创 Size by Application
2.5.1 Breast Cancer Treatment Devices 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Breast Cancer Treatment Devices 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Breast Cancer Treatment Devices 麻豆原创 Size by Player
3.1 Breast Cancer Treatment Devices 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Breast Cancer Treatment Devices Revenue by Player (2020-2025)
3.1.2 Global Breast Cancer Treatment Devices Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Breast Cancer Treatment Devices Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Breast Cancer Treatment Devices by Region
4.1 Breast Cancer Treatment Devices 麻豆原创 Size by Region (2020-2025)
4.2 Global Breast Cancer Treatment Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Breast Cancer Treatment Devices 麻豆原创 Size Growth (2020-2025)
4.4 APAC Breast Cancer Treatment Devices 麻豆原创 Size Growth (2020-2025)
4.5 Europe Breast Cancer Treatment Devices 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Breast Cancer Treatment Devices 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Breast Cancer Treatment Devices 麻豆原创 Size by Country (2020-2025)
5.2 Americas Breast Cancer Treatment Devices 麻豆原创 Size by Type (2020-2025)
5.3 Americas Breast Cancer Treatment Devices 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Cancer Treatment Devices 麻豆原创 Size by Region (2020-2025)
6.2 APAC Breast Cancer Treatment Devices 麻豆原创 Size by Type (2020-2025)
6.3 APAC Breast Cancer Treatment Devices 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Breast Cancer Treatment Devices 麻豆原创 Size by Country (2020-2025)
7.2 Europe Breast Cancer Treatment Devices 麻豆原创 Size by Type (2020-2025)
7.3 Europe Breast Cancer Treatment Devices 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breast Cancer Treatment Devices by Region (2020-2025)
8.2 Middle East & Africa Breast Cancer Treatment Devices 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Breast Cancer Treatment Devices 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Breast Cancer Treatment Devices 麻豆原创 Forecast
10.1 Global Breast Cancer Treatment Devices Forecast by Region (2026-2031)
10.1.1 Global Breast Cancer Treatment Devices Forecast by Region (2026-2031)
10.1.2 Americas Breast Cancer Treatment Devices Forecast
10.1.3 APAC Breast Cancer Treatment Devices Forecast
10.1.4 Europe Breast Cancer Treatment Devices Forecast
10.1.5 Middle East & Africa Breast Cancer Treatment Devices Forecast
10.2 Americas Breast Cancer Treatment Devices Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Breast Cancer Treatment Devices Forecast
10.2.2 Canada 麻豆原创 Breast Cancer Treatment Devices Forecast
10.2.3 Mexico 麻豆原创 Breast Cancer Treatment Devices Forecast
10.2.4 Brazil 麻豆原创 Breast Cancer Treatment Devices Forecast
10.3 APAC Breast Cancer Treatment Devices Forecast by Region (2026-2031)
10.3.1 China Breast Cancer Treatment Devices 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Breast Cancer Treatment Devices Forecast
10.3.3 Korea 麻豆原创 Breast Cancer Treatment Devices Forecast
10.3.4 Southeast Asia 麻豆原创 Breast Cancer Treatment Devices Forecast
10.3.5 India 麻豆原创 Breast Cancer Treatment Devices Forecast
10.3.6 Australia 麻豆原创 Breast Cancer Treatment Devices Forecast
10.4 Europe Breast Cancer Treatment Devices Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Breast Cancer Treatment Devices Forecast
10.4.2 France 麻豆原创 Breast Cancer Treatment Devices Forecast
10.4.3 UK 麻豆原创 Breast Cancer Treatment Devices Forecast
10.4.4 Italy 麻豆原创 Breast Cancer Treatment Devices Forecast
10.4.5 Russia 麻豆原创 Breast Cancer Treatment Devices Forecast
10.5 Middle East & Africa Breast Cancer Treatment Devices Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Breast Cancer Treatment Devices Forecast
10.5.2 South Africa 麻豆原创 Breast Cancer Treatment Devices Forecast
10.5.3 Israel 麻豆原创 Breast Cancer Treatment Devices Forecast
10.5.4 Turkey 麻豆原创 Breast Cancer Treatment Devices Forecast
10.6 Global Breast Cancer Treatment Devices Forecast by Type (2026-2031)
10.7 Global Breast Cancer Treatment Devices Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Breast Cancer Treatment Devices Forecast
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Breast Cancer Treatment Devices Product Offered
11.1.3 Abbott Laboratories Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Advanced Radiation Therapy
11.2.1 Advanced Radiation Therapy Company Information
11.2.2 Advanced Radiation Therapy Breast Cancer Treatment Devices Product Offered
11.2.3 Advanced Radiation Therapy Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Advanced Radiation Therapy Main Business Overview
11.2.5 Advanced Radiation Therapy Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Breast Cancer Treatment Devices Product Offered
11.3.3 Agilent Technologies Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Becton
11.4.1 Becton Company Information
11.4.2 Becton Breast Cancer Treatment Devices Product Offered
11.4.3 Becton Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Becton Main Business Overview
11.4.5 Becton Latest Developments
11.5 Xcision Medical Systems, LLC
11.5.1 Xcision Medical Systems, LLC Company Information
11.5.2 Xcision Medical Systems, LLC Breast Cancer Treatment Devices Product Offered
11.5.3 Xcision Medical Systems, LLC Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Xcision Medical Systems, LLC Main Business Overview
11.5.5 Xcision Medical Systems, LLC Latest Developments
11.6 BioGenex Laboratories
11.6.1 BioGenex Laboratories Company Information
11.6.2 BioGenex Laboratories Breast Cancer Treatment Devices Product Offered
11.6.3 BioGenex Laboratories Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 BioGenex Laboratories Main Business Overview
11.6.5 BioGenex Laboratories Latest Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Information
11.7.2 Danaher Corporation Breast Cancer Treatment Devices Product Offered
11.7.3 Danaher Corporation Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Danaher Corporation Main Business Overview
11.7.5 Danaher Corporation Latest Developments
11.8 Fujifilm Holdings Corporation
11.8.1 Fujifilm Holdings Corporation Company Information
11.8.2 Fujifilm Holdings Corporation Breast Cancer Treatment Devices Product Offered
11.8.3 Fujifilm Holdings Corporation Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Fujifilm Holdings Corporation Main Business Overview
11.8.5 Fujifilm Holdings Corporation Latest Developments
11.9 GE Healthcare
11.9.1 GE Healthcare Company Information
11.9.2 GE Healthcare Breast Cancer Treatment Devices Product Offered
11.9.3 GE Healthcare Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 GE Healthcare Main Business Overview
11.9.5 GE Healthcare Latest Developments
11.10 General Medical Merate SpA
11.10.1 General Medical Merate SpA Company Information
11.10.2 General Medical Merate SpA Breast Cancer Treatment Devices Product Offered
11.10.3 General Medical Merate SpA Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 General Medical Merate SpA Main Business Overview
11.10.5 General Medical Merate SpA Latest Developments
11.11 Hologic
11.11.1 Hologic Company Information
11.11.2 Hologic Breast Cancer Treatment Devices Product Offered
11.11.3 Hologic Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Hologic Main Business Overview
11.11.5 Hologic Latest Developments
11.12 iCAD Inc.
11.12.1 iCAD Inc. Company Information
11.12.2 iCAD Inc. Breast Cancer Treatment Devices Product Offered
11.12.3 iCAD Inc. Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 iCAD Inc. Main Business Overview
11.12.5 iCAD Inc. Latest Developments
11.13 IceCure Medical Ltd
11.13.1 IceCure Medical Ltd Company Information
11.13.2 IceCure Medical Ltd Breast Cancer Treatment Devices Product Offered
11.13.3 IceCure Medical Ltd Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 IceCure Medical Ltd Main Business Overview
11.13.5 IceCure Medical Ltd Latest Developments
11.14 IntraOp Medical Corporation
11.14.1 IntraOp Medical Corporation Company Information
11.14.2 IntraOp Medical Corporation Breast Cancer Treatment Devices Product Offered
11.14.3 IntraOp Medical Corporation Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 IntraOp Medical Corporation Main Business Overview
11.14.5 IntraOp Medical Corporation Latest Developments
11.15 Myriad Genetics
11.15.1 Myriad Genetics Company Information
11.15.2 Myriad Genetics Breast Cancer Treatment Devices Product Offered
11.15.3 Myriad Genetics Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Myriad Genetics Main Business Overview
11.15.5 Myriad Genetics Latest Developments
11.16 Parascript, LLC
11.16.1 Parascript, LLC Company Information
11.16.2 Parascript, LLC Breast Cancer Treatment Devices Product Offered
11.16.3 Parascript, LLC Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Parascript, LLC Main Business Overview
11.16.5 Parascript, LLC Latest Developments
11.17 Philips Healthcare
11.17.1 Philips Healthcare Company Information
11.17.2 Philips Healthcare Breast Cancer Treatment Devices Product Offered
11.17.3 Philips Healthcare Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Philips Healthcare Main Business Overview
11.17.5 Philips Healthcare Latest Developments
11.18 Planmed Oy
11.18.1 Planmed Oy Company Information
11.18.2 Planmed Oy Breast Cancer Treatment Devices Product Offered
11.18.3 Planmed Oy Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Planmed Oy Main Business Overview
11.18.5 Planmed Oy Latest Developments
11.19 Qiagen NV
11.19.1 Qiagen NV Company Information
11.19.2 Qiagen NV Breast Cancer Treatment Devices Product Offered
11.19.3 Qiagen NV Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Qiagen NV Main Business Overview
11.19.5 Qiagen NV Latest Developments
11.20 Roche Holding AG
11.20.1 Roche Holding AG Company Information
11.20.2 Roche Holding AG Breast Cancer Treatment Devices Product Offered
11.20.3 Roche Holding AG Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Roche Holding AG Main Business Overview
11.20.5 Roche Holding AG Latest Developments
11.21 Sanarus Technologies Inc.
11.21.1 Sanarus Technologies Inc. Company Information
11.21.2 Sanarus Technologies Inc. Breast Cancer Treatment Devices Product Offered
11.21.3 Sanarus Technologies Inc. Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Sanarus Technologies Inc. Main Business Overview
11.21.5 Sanarus Technologies Inc. Latest Developments
11.22 Siemens Healthineers AG
11.22.1 Siemens Healthineers AG Company Information
11.22.2 Siemens Healthineers AG Breast Cancer Treatment Devices Product Offered
11.22.3 Siemens Healthineers AG Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.22.4 Siemens Healthineers AG Main Business Overview
11.22.5 Siemens Healthineers AG Latest Developments
11.23 Thermo Fisher Scientific
11.23.1 Thermo Fisher Scientific Company Information
11.23.2 Thermo Fisher Scientific Breast Cancer Treatment Devices Product Offered
11.23.3 Thermo Fisher Scientific Breast Cancer Treatment Devices Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.23.4 Thermo Fisher Scientific Main Business Overview
11.23.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
